TWA
ACOR

TCI Wealth Advisors’s Acorda Therapeutics ACOR Stock Holding History

TCI Wealth Advisors’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1
Closed -$1K – 1718
2018
Q3 		$1K Hold
1
– – ﹤0.01% 1388
2018
Q2 		$2K Hold
1
– – ﹤0.01% 1179
2018
Q1 		$2K Hold
1
– – ﹤0.01% 1037
2017
Q4 		$2K Buy
+1
New +$2.84K ﹤0.01% 1087
2017
Q3 		– Hold
0
– – – 1235
2017
Q2 		– Sell
-1
Closed -$2K – 1394
2017
Q1 		$2K Hold
1
– – ﹤0.01% 997
2016
Q4 		$2K Buy
+1
New +$2.38K ﹤0.01% 1070
2016
Q3 		– Hold
0
– – – 1420
2016
Q2 		– Hold
0
– – – 1404

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TCI Wealth Advisors's ACOR Position: Q4 2018 in Review

TCI Wealth Advisors sold out of Acorda Therapeutics (ACOR) in Q4 2018, closing a stake of 1 share — an estimated $1K sold.

TCI Wealth Advisors first reported a position in ACOR in Q4 2016 and held it in 6 quarters. The position peaked at $2K in Q2 2018. 179 funds tracked by Wall St. Rank hold ACOR as of Q4 2018.

  • TCI Wealth Advisors reported no remaining Acorda Therapeutics position as of Q4 2018 after selling out during the quarter.
  • TCI Wealth Advisors sold 1 Acorda Therapeutics share in Q4 2018, an estimated $1K.
  • TCI Wealth Advisors first reported a position in Acorda Therapeutics in Q4 2016 and held it in 6 quarters.
  • TCI Wealth Advisors's Acorda Therapeutics position peaked at $2K in Q2 2018.
  • 179 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2018.

Based on TCI Wealth Advisors's 13F filing for Q4 2018, filed 17 Jan 2019.